1076 related articles for article (PubMed ID: 29388198)
21. Gonadotrophins for ovulation induction in women with polycystic ovary syndrome.
Weiss NS; Kostova E; Nahuis M; Mol BWJ; van der Veen F; van Wely M
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD010290. PubMed ID: 30648738
[TBL] [Abstract][Full Text] [Related]
22. A randomised controlled trial to clinically validate follitropin delta in its individualised dosing regimen for ovarian stimulation in Asian IVF/ICSI patients.
Qiao J; Zhang Y; Liang X; Ho T; Huang HY; Kim SH; Goethberg M; Mannaerts B; Arce JC
Hum Reprod; 2021 Aug; 36(9):2452-2462. PubMed ID: 34179971
[TBL] [Abstract][Full Text] [Related]
23. Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles.
Youssef MA; Abou-Setta AM; Lam WS
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD003719. PubMed ID: 27106604
[TBL] [Abstract][Full Text] [Related]
24. Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection.
Brown J; Daya S; Matson P
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD004378. PubMed ID: 27976360
[TBL] [Abstract][Full Text] [Related]
25. The addition of anti-Müllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response-a randomized, controlled trial.
Magnusson Å; Nilsson L; Oleröd G; Thurin-Kjellberg A; Bergh C
Hum Reprod; 2017 Apr; 32(4):811-819. PubMed ID: 28175316
[TBL] [Abstract][Full Text] [Related]
26. Do female age and body weight modify the effect of individualized FSH dosing in IVF/ICSI treatment? A secondary analysis of the OPTIMIST trial.
Leijdekkers JA; van Tilborg TC; Torrance HL; Oudshoorn SC; Brinkhuis EA; Koks CAM; Lambalk CB; de Bruin JP; Fleischer K; Mochtar MH; Kuchenbecker WKH; Laven JSE; Mol BWJ; Broekmans FJM; Eijkemans MJC;
Acta Obstet Gynecol Scand; 2019 Oct; 98(10):1332-1340. PubMed ID: 31127607
[TBL] [Abstract][Full Text] [Related]
27. In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction.
Siristatidis CS; Maheshwari A; Vaidakis D; Bhattacharya S
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD006606. PubMed ID: 30480769
[TBL] [Abstract][Full Text] [Related]
28. Dopamine agonists for preventing ovarian hyperstimulation syndrome.
Tang H; Mourad SM; Wang A; Zhai SD; Hart RJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD008605. PubMed ID: 33851429
[TBL] [Abstract][Full Text] [Related]
29. Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.
Siristatidis CS; Gibreel A; Basios G; Maheshwari A; Bhattacharya S
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD006919. PubMed ID: 26558801
[TBL] [Abstract][Full Text] [Related]
30. Endometrial injury in women undergoing in vitro fertilisation (IVF).
Lensen SF; Armstrong S; Gibreel A; Nastri CO; Raine-Fenning N; Martins WP
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD009517. PubMed ID: 34110001
[TBL] [Abstract][Full Text] [Related]
31. Increased versus standard gonadotrophin dosing in predicted poor responders of IVF: an open-label randomized controlled trial.
Liu X; Wen W; Wang T; Tian L; Li N; Sun T; Wang T; Zhou H; Zhang N; Qu P; Mol BW; Li W; Shi J
Hum Reprod; 2022 Jul; 37(8):1806-1815. PubMed ID: 35595197
[TBL] [Abstract][Full Text] [Related]
32. Glucocorticoid supplementation during ovarian stimulation for IVF or ICSI.
Kalampokas T; Pandian Z; Keay SD; Bhattacharya S
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD004752. PubMed ID: 28349525
[TBL] [Abstract][Full Text] [Related]
33. Interventions for unexplained infertility: a systematic review and network meta-analysis.
Wang R; Danhof NA; Tjon-Kon-Fat RI; Eijkemans MJ; Bossuyt PM; Mochtar MH; van der Veen F; Bhattacharya S; Mol BWJ; van Wely M
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD012692. PubMed ID: 31486548
[TBL] [Abstract][Full Text] [Related]
34. Fresh versus frozen embryo transfers in assisted reproduction.
Wong KM; van Wely M; Mol F; Repping S; Mastenbroek S
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011184. PubMed ID: 28349510
[TBL] [Abstract][Full Text] [Related]
35. Luteal phase support for assisted reproduction cycles.
van der Linden M; Buckingham K; Farquhar C; Kremer JA; Metwally M
Cochrane Database Syst Rev; 2011 Oct; (10):CD009154. PubMed ID: 21975790
[TBL] [Abstract][Full Text] [Related]
36. FSH replaced by low-dose hCG in the late follicular phase versus continued FSH for assisted reproductive techniques.
Martins WP; Vieira AD; Figueiredo JB; Nastri CO
Cochrane Database Syst Rev; 2013 Mar; (3):CD010042. PubMed ID: 23543584
[TBL] [Abstract][Full Text] [Related]
37. Metformin during ovulation induction with gonadotrophins followed by timed intercourse or intrauterine insemination for subfertility associated with polycystic ovary syndrome.
Bordewijk EM; Nahuis M; Costello MF; Van der Veen F; Tso LO; Mol BW; van Wely M
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD009090. PubMed ID: 28118681
[TBL] [Abstract][Full Text] [Related]
38. Long-acting FSH versus daily FSH for women undergoing assisted reproduction.
Pouwer AW; Farquhar C; Kremer JA
Cochrane Database Syst Rev; 2012 Jun; (6):CD009577. PubMed ID: 22696386
[TBL] [Abstract][Full Text] [Related]
39. Dopamine agonists for preventing ovarian hyperstimulation syndrome.
Tang H; Mourad S; Zhai SD; Hart RJ
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD008605. PubMed ID: 27901279
[TBL] [Abstract][Full Text] [Related]
40. Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis.
Georgiou EX; Melo P; Baker PE; Sallam HN; Arici A; Garcia-Velasco JA; Abou-Setta AM; Becker C; Granne IE
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31747470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
